GlassScriptPhysician profile
David R Baker
NPI 1598998247
$2,091.90
in general payments reported to CMS, 2019-2025
19 companies · $24.23 in 2025
The $24.23 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $754 · 2022: $812 · 2023: $458 · 2024: $43.07 · 2025: $24.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $510 · Education: $15.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $510.27 |
| Education | $15.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $588.85 | 2021-2022 | |
| Genzyme Corporation | $301.37 | 2021-2023 | |
| Novartis Pharmaceuticals Corporation | $205.00 | 2021-2023 | |
| Lilly USA, LLC | $176.39 | 2021-2023 | Taltz, Olumiant |
| Janssen Biotech, INC. | $127.94 | 2021-2023 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $127.52 | 2022-2025 | Libtayo, Dupixent |
| Sanofi-Aventis U.S. LLC | $79.99 | 2021 | |
| Organogenesis INC. | $64.73 | 2021-2023 | Puraply |
| Amgen INC. | $64.53 | 2021-2022 | |
| Biofrontera INC. | $62.19 | 2021-2023 | Xepi, Bf-Rhodoled, Ameluz |
| Pfizer INC. | $58.69 | 2021-2023 | |
| Incyte Corporation | $51.41 | 2022-2023 | Opzelura |
| Genentech USA, INC. | $50.56 | 2023-2024 | Erivedge |
| E.R. Squibb & Sons, L.L.C. | $48.75 | 2022-2023 | Sotyktu |
| Convatec INC. | $24.71 | 2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $15.64 | 2022 | |
| Pharmacyclics LLC, An Abbvie Company | $15.58 | 2023 | Imbruvica |
| Galderma Laboratories, L.P. | $15.22 | 2022 | |
| Genentech, INC. | $12.83 | 2023 | Erivedge |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.